優殖有限公司
李天立(01研究院病理解剖及細胞學);生物醫學學院副教授
陳耀樑(06研究院外科學);婦產科學系研究助理教授
何亦平 生物醫學工程學系助理教授
陳漢輝 生物醫學學院助理教授

項目簡介|PROJECT SUMMARY

The poor in vitro fertilisation (IVF) outcomes faced by women with limited usable eggs (oocytes) has been a huge challenge. We developed a novel cell-based treatment to rescue the discard oocytes in the conventional IVF procedure known as EggBoost, which is facilitated by a patented lab-on-a-chip device. The technology increases IVF success rate through and quantitative and qualitative improvements on oocytes, thus easing the financial and emotional stress of IVF customers.

發展階段|STAGE OF DEVELOPMENT

Ready to launch

產品特點|DISTINGUISHED FEATURES

  • Produce more usable oocytes for women struggling with limited oocytes in IVF procedure
  • The lab-on-a-chip platform allows cell trapping structures in a low volume culture chamber
  • Non-invasive and autologous (no genetic material transfer)
  • No use of viral or physical vectors reducing chances of oocyte damage

如何解決市場痛點|RESPONSE TO MARKET PAIN POINTS

Over 90% of women seeking help from assisted reproductive technologies (ARTs) are of Advanced Maternal Age (AMA) 35 years or above. At this stage oxidative stress in oocytes decreases the cellular energy functions, impeding the maturation process required before fertilisation and increasing adverse pregnancy outcomes. We have shown that oocytes can be rescued through a natural transfer of an energy-producing organelle through a tiny chip device. Further, plans to implement machined automation will reduce human error and involvement. The ability of our technology to target both oocyte maturation rate and quality desirably tackle key pain points in the IVF market.

現在尋找…|LOOKING FOR…

  • 資金 Funding
  • 創業夥伴 Partners
  • 曝光機會 Visibility and Exposure

公司網址|WEBSITE

www.egglogics.com

社交媒體|SOCIAL MEDIA

聯絡|CONTACT